Masaki E, Kondo I
Department of Pharmacology (I), Jikei University School of Medicine, Tokyo, Japan.
Anesth Analg. 1999 Aug;89(2):484-9. doi: 10.1097/00000539-199908000-00045.
The nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signal pathway plays an important role in anesthetic and analgesic effects. We sought to determine the involvement of inhibition of soluble guanylyl cyclase (sGC) in the anesthetic mechanism and site of action of volatile anesthetics. We examined the effect of intracerebroventricular (ICV) administration of methylene blue (MB), a sGC inhibitor, on the minimum alveolar anesthetic concentration (MAC) of sevoflurane and the brain cGMP content in rats in vivo. We also investigated the effect of sevoflurane on NO-stimulated sGC activity in vitro. The rats were divided into three groups. After the ICV administration of MB, sevoflurane MAC and brain cGMP contents were measured in the first group and the second group, respectively. In the third group, brain cGMP contents were determined after sevoflurane anesthesia without the ICV administration of MB to examine the direct effect of sevoflurane on brain cGMP contents. MB significantly decreased sevoflurane MAC and brain cGMP content in a dose-dependent manner. Sevoflurane itself also dose-dependently decreased cGMP contents in brain in vivo and inhibited the NO-stimulated sGC activity in vitro. These results suggest that the inhibition of the NO-cGMP signal pathway at the sGC level could be involved in anesthetic or analgesic effects, and the inhibitory effect of sevoflurane on sGC would be one of the sites of action of this anesthetic.
Because the nitric oxide-cyclic guanosine monophosphate signal pathway mediates nociception and the site of action of halogenated volatile anesthetics in uncertain, we examined the possible involvement of inhibition of soluble guanylyl cyclase in the anesthetic mechanism. The inhibitory effect of sevoflurane on soluble guanylyl cyclase could be one of sites of this anesthetic.
一氧化氮(NO)-环磷酸鸟苷(cGMP)信号通路在麻醉和镇痛作用中起重要作用。我们试图确定可溶性鸟苷酸环化酶(sGC)的抑制作用在挥发性麻醉药的麻醉机制和作用部位中的参与情况。我们研究了脑室内(ICV)注射sGC抑制剂亚甲蓝(MB)对七氟醚最低肺泡有效浓度(MAC)以及大鼠体内脑cGMP含量的影响。我们还在体外研究了七氟醚对NO刺激的sGC活性的影响。大鼠被分为三组。在第一组中,ICV注射MB后测量七氟醚MAC,在第二组中测量脑cGMP含量。在第三组中,在未进行ICV注射MB的情况下给予七氟醚麻醉后测定脑cGMP含量,以研究七氟醚对脑cGMP含量的直接影响。MB以剂量依赖的方式显著降低七氟醚MAC和脑cGMP含量。七氟醚本身在体内也以剂量依赖的方式降低脑cGMP含量,并在体外抑制NO刺激的sGC活性。这些结果表明,在sGC水平对NO-cGMP信号通路的抑制可能参与麻醉或镇痛作用,七氟醚对sGC的抑制作用将是这种麻醉药的作用部位之一。
由于一氧化氮-环磷酸鸟苷信号通路介导伤害感受且卤代挥发性麻醉药的作用部位尚不确定,我们研究了可溶性鸟苷酸环化酶抑制作用在麻醉机制中的可能参与情况。七氟醚对可溶性鸟苷酸环化酶的抑制作用可能是这种麻醉药的作用部位之一。